CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report)'s stock price rose 0.9% during mid-day trading on Tuesday . The company traded as high as $99.27 and last traded at $98.81. Approximately 9,253 shares changed hands during trading, an increase of 459% from the average daily volume of 1,655 shares. The stock had previously closed at $97.97.
Wall Street Analyst Weigh In
CHEOY has been the subject of a number of research reports. UBS Group upgraded CochLear from a "hold" rating to a "strong-buy" rating in a report on Wednesday, June 18th. Zacks Research upgraded CochLear to a "hold" rating in a report on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy".
Check Out Our Latest Report on CochLear
CochLear Price Performance
The stock has a fifty day simple moving average of $99.16 and a two-hundred day simple moving average of $90.19.
About CochLear
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CochLear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.
While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access